Electromed Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Electromed Inc in the fourth quarter 2026?
Electromed Inc achieved a return on average equity (ROE) of 23.65 % in its fourth quarter 2026 a new company high.

ROE has advanced compared to 22.41% in the third quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 11 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 585, from total ROE ranking in the third quarter 2026 at 604.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter
Y / Y Equity Change	24.93 %	11.9 %	-3 %	7.85 %	-
Y / Y Net Income Change	54.31 %	58.8 %	40.29 %	44.91 %	20.57 %
Net Income (TTM) in Millions	11	10	9	8	8
Return On Equity (TTM)	23.65 %	22.41 %	20.54 %	18.59 %	17.41 %
ELMD's Total Ranking	# 585	# 604	# 560	# 591	# 628
Equity (TTM) in Millions	54	49	43	45	43
Seq. Equity Change	9.79 %	13.79 %	-3.43 %	3.55 %	-1.66 %
Seq. Net Income Change	13.25 %	8.76 %	29.26 %	-3.09 %	16.55 %

Back to ELMD Management Effectiveness >> ELMD's 5 Years Annual ROE >> Compare ELMD ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 12
Sector	# 71
Overall	# 585

Return On Equity Statistics
High	Average	Low
23.65 %	8.19 %	-14.8 %
(Jun 30 2026)		(Mar 31 2014)

ELMD Annual Return On Equity	(Jun 30 2026) 2026	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022
Total Equity in Millions	54	43	45	38	34
Y / Y Equity Change	24.93 %	-3 %	18.26 %	10.22 %	5.42 %
Net Income in Millions	11	8	5	3	2
Y / Y Net Income Change	49.94 %	46.35 %	62.67 %	37.35 %	-2.41 %
Return On Equity	20.94 %	17.44 %	11.56 %	8.41 %	6.75 %

Back to ELMD Management Effectiveness >> ELMD's 5 Years Annual ROE >> Compare ELMD ROE to its Competitors

Annual Roe Comment

In 2026 ROE improved to 20.94 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ELMD's' Return on Equity at Yahoo Finance
ELMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ELMD's Competitors
Subscribers only: Roe for Electromed Inc 's Suppliers
Subscribers only: Return On Equity for ELMD's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Aurinia Pharmaceuticals Inc	59.00 %
Vaxart Inc	53.04 %
Qhslab Inc	51.21 %
Tenet Healthcare Corp	50.64 %
Nrc Health	48.29 %
Concentra Group Holdings Parent Inc	48.13 %
Bristol myers Squibb Company	46.65 %
Agilent Technologies inc	41.99 %
Eton Pharmaceuticals Inc	40.13 %
Adma Biologics Inc	39.59 %
Dexcom Inc	36.25 %
Transmedics Group Inc	33.37 %
Arcutis Biotherapeutics Inc	32.92 %
Caredx Inc	32.81 %
Zevra Therapeutics Inc	32.56 %
Acadia Pharmaceuticals Inc	32.39 %
Pro dex Inc	31.96 %
Protalix Biotherapeutics inc	31.61 %
Illumina Inc	31.08 %
Innoviva Inc	30.03 %
Phibro Animal Health Corporation	29.66 %
Chemed Corporation	29.45 %
Solventum Corporation	28.96 %
Pacs Group Inc	27.00 %
Sotera Health Company	26.75 %
Insulet Corporation	26.69 %
Bioventus Inc	25.96 %
Johnson and Johnson	25.74 %
Encompass Health Corporation	25.52 %
Resmed Inc	24.21 %

Date modified: 2026-09-08T15:22:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.